Pouillart P - Search Results

1

Lack of effect of tumour infiltrating lymphocytes in patients with metastatic melanoma who failed to respond to interleukin 2.

Dorval T, Mathiot C, Brandely M, Escande MC, Fridman WH, Pouillart P. Dorval T, et al. Among authors: pouillart p. Eur J Cancer. 1992;28(2-3):615-6. doi: 10.1016/s0959-8049(05)80107-8. Eur J Cancer. 1992. PMID: 1591084 No abstract available.

2

Phenotypic and functional analysis of tumour-infiltrating lymphocytes from patients with melanoma and other metastatic cancers.

Mathiot C, Robin E, Gey A, Weng X, Dorval T, Pouillart P, Sastre X, Zerbib M, Hamelin JP, Salmon R, et al. Mathiot C, et al. Among authors: pouillart p. Eur J Cancer. 1992;28(2-3):345-50. doi: 10.1016/s0959-8049(05)80051-6. Eur J Cancer. 1992. PMID: 1591049

3

Interleukin-2 therapy for metastatic uveal melanoma.

Dorval T, Fridman WH, Mathiot C, Pouillart P. Dorval T, et al. Among authors: pouillart p. Eur J Cancer. 1992;28A(12):2087. doi: 10.1016/0959-8049(92)90266-5. Eur J Cancer. 1992. PMID: 1419309 Clinical Trial. No abstract available.

4

Malignant melanoma: treatment of metastatic meningitis with intrathecal interferon alpha-2b.

Dorval T, Beuzeboc P, Garcia-Giralt E, Jouve M, Palangie T, Pouillart P. Dorval T, et al. Among authors: pouillart p. Eur J Cancer. 1992;28(1):244-5. doi: 10.1016/0959-8049(92)90420-7. Eur J Cancer. 1992. PMID: 1567672 No abstract available.

5

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients.

Tartour E, Dorval T, Mosseri V, Deneux L, Mathiot C, Brailly H, Montero F, Joyeux I, Pouillart P, Fridman WH. Tartour E, et al. Among authors: pouillart p. Br J Cancer. 1994 May;69(5):911-3. doi: 10.1038/bjc.1994.175. Br J Cancer. 1994. PMID: 8180022 Free PMC article.

6

IL-2 phase II trial in metastatic melanoma: analysis of clinical and immunological parameters.

Dorval T, Mathiot C, Chosidow O, Revuz J, Avril MF, Guillaume JC, Tursz T, Brandely M, Pouillart P, Fridman WH. Dorval T, et al. Among authors: pouillart p. Biotechnol Ther. 1992;3(1-2):63-79. Biotechnol Ther. 1992. PMID: 1305893 Clinical Trial.

7

[Treatment of metastatic malignant melanoma with interleukin-2].

Dorval T, Fridman WH, Mathiot C, Sastre X, Pouillart P. Dorval T, et al. Among authors: pouillart p. Bull Cancer. 1992;79(8):781-7. Bull Cancer. 1992. PMID: 1467601 French.

8

[Role of cell therapy in the management of cancer].

Fridman WH, Mathiot C, Tartour E, Dorval T, Thiounn N, Pouillart P, Debre B. Fridman WH, et al. Among authors: pouillart p. Bull Cancer. 1995 Mar;82(3):235-6. Bull Cancer. 1995. PMID: 7655161 French. No abstract available.

9

A rapidly progressing leiomyosarcoma expressing drug-resistance markers failed to respond to cyclosporin A-associated chemotherapy.

Oudard S, Chevillard S, Lokiec F, Dorval T, Poupon MF, Pouillart P. Oudard S, et al. Among authors: pouillart p. Eur J Cancer. 1994;30A(10):1594. doi: 10.1016/0959-8049(94)90068-x. Eur J Cancer. 1994. PMID: 7833127 No abstract available.

10

Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings.

Tartour E, Mehtali M, Sastre-Garau X, Joyeux I, Mathiot C, Pleau JM, Squiban P, Rochlitz C, Courtney M, Jantscheff P, Herrmann R, Pouillart P, Fridman WH, Dorval T. Tartour E, et al. Among authors: pouillart p. Br J Cancer. 2000 Dec;83(11):1454-61. doi: 10.1054/bjoc.2000.1492. Br J Cancer. 2000. PMID: 11076653 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters